Deal secured for cancer drug
PHARMACEUTICAL company ProStrakan has secured a deal to sell its drug for cancer pain across Germany.
The Galashiels-based firm has announced that Abstral will be launched in the country at the beginning of next year.
The drug – formerly branded as Rapinyl – is a fast-dissolving tablet which is placed under a patient's tongue to manage breakthrough cancer pain.
Chief executive Dr Wilson Totten said: "Our German operation is well advanced in its preparations for launch and we look forward to introducing German oncologists to this important product for cancer patients."
ProStrakan has just received marketing authorisation from the German regulatory authority BfArM for Abstral.
Email to a friend
Print this page
Looking for...
Featured advertisers
Jobs
Search for a job
Motors
Search for a car
Property
Search for a house
Weather for Edinburgh
Monday 28 May 2012
Today
Sunny
Temperature: 9 C to 21 C
Wind Speed: 15 mph
Wind direction: North east
Tomorrow
Cloudy
Temperature: 10 C to 16 C
Wind Speed: 12 mph
Wind direction: North east
